This study focuses on pelvic exenteration as a solution for chronic fistulating pelvic sepsis, a rare complication stemming from pelvic cancer treatment. The research includes 19 patients who underwent radical resection after previous pelvic cancer treatments. Promisingly, the procedure proved safe and effective, with no intraoperative or postoperative deaths. While some patients faced major complications and readmissions, 74% ultimately showed no signs or symptoms of persistent pelvic sepsis, emphasizing the efficacy of pelvic exenteration for selected cases.
Journal Article by Brown KGM, Risbey C (…) Byrne CM et 3 al. in Eur J Surg Oncol
© 2023 Published by Elsevier Ltd.